• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

GTXI:US

1.3400 USD 0.0100 0.75%

As of 20:10:00 ET on 07/11/2014.

Company Profile for GTx Inc (GTXI)

GTx, Inc. discovers, develops, and commercializes therapeutics primarily related to the treatment of serious men's health conditions. The Company's drug discover and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones. GTx is currently developing products for prostate cancer.

Contact Information

GTx Inc

175 Toyota Plaza
7th Floor
Memphis, TN 38103
United States
Phone: 1-901-523-9700
Fax: 1-901-644-8075

Key Executives for GTx Inc (GTXI)

Marc S HanoverPresident/Interim CEO/COOHenry P DoggrellVP/Chief Legal Officer/Secy
James T DaltonVP/Chief Scientific OfficerJeffrey G HesselbergVP:Regulatory Affairs
Mary Ann JohnstonVP:Medical Affairs

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil